Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2016 - 2025)
Zimmer Biomet Holdings has reported Change in Accured Expenses over the past 17 years, most recently at $112.9 million for Q4 2025.
- Quarterly results put Change in Accured Expenses at $112.9 million for Q4 2025, up 196.25% from a year ago — trailing twelve months through Dec 2025 was $101.8 million (up 131.61% YoY), and the annual figure for FY2025 was $101.8 million, up 131.61%.
- Change in Accured Expenses for Q4 2025 was $112.9 million at Zimmer Biomet Holdings, up from -$51.5 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for ZBH hit a ceiling of $164.2 million in Q4 2023 and a floor of -$138.3 million in Q1 2021.
- Median Change in Accured Expenses over the past 5 years was -$28.6 million (2022), compared with a mean of -$4.3 million.
- Biggest five-year swings in Change in Accured Expenses: tumbled 477.36% in 2023 and later surged 223.67% in 2025.
- Zimmer Biomet Holdings' Change in Accured Expenses stood at $64.0 million in 2021, then soared by 63.44% to $104.6 million in 2022, then skyrocketed by 56.98% to $164.2 million in 2023, then plummeted by 171.44% to -$117.3 million in 2024, then surged by 196.25% to $112.9 million in 2025.
- The last three reported values for Change in Accured Expenses were $112.9 million (Q4 2025), -$51.5 million (Q3 2025), and $76.8 million (Q2 2025) per Business Quant data.